Gastric Cancer Complicated With Bleeding
To investigate the impact of bleeding on the survival and treatment-related adverse events (TRAEs) of gastric cancer patients.
Gastric Cancer
DRUG: systematic therapy
Overall survival (OS), OS was defined as the time from the first cycle of systematic therapy to death from any cause., from date of the first cycle of systematic therapy to death from any causeï¼Œassessed up to 120 months
We will retrospectively enroll patients diagnosed with advanced or metastatic gastric cancer at the Department of Medical Oncology and Radiation Sickness of Peking University Third Hospital. The retrospective study aims to investigate the impact of bleeding on treatment-related adverse events (TRAEs) for gastric cancer patients receiving systematic anticancer treatment, assess the influence of bleeding on the survival of patients.